Placeholder Banner

BIO Applauds Passage of Federal Approach to GMO Disclosure

July 14, 2016

Washington, D.C. (July 14, 2016) – The Biotechnology Innovation Organization (BIO) welcomes Congressional passage of a federal, uniform approach to GMO disclosure. 

“The Congress’ strong, bipartisan support for a national GMO labeling and disclosure solution is a win for consumers, farmers, businesses, and agricultural innovation,” said Jim Greenwood, BIO’s President and CEO.

“More than one thousand stakeholder organizations came together in support of this agreement and we commend the many leaders in the U.S. Congress for making this issue a top priority,” added Greenwood.  “We are pleased that President Obama has said he will sign this important bill.”

Discover More
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…